Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Naubourg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
IEEE Journal of Biomedical and Health Informatics|August 11, 2015
eClims: An Extensible and Dynamic Integration Framework for Biomedical Information SystemsMarinette Savonnet, Eric Leclercq, Pierre Naubourg
International Journal of Neonatal Screening|October 19, 2020
The Reliable, Automatic Classification of Neonates in First-Tier MALDI-MS Screening for Sickle Cell DiseaseMarven El Osta, Pierre Naubourg, Olivier Grunewald, et al.
International Journal of Neonatal Screening|October 19, 2020
A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS PlatformPierre Naubourg, Marven El Osta, David Rageot, et al.
Clinical Chemistry and Laboratory Medicine|February 14, 2024
MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLCMarven El Osta, Jean-François Benoist, Pierre Naubourg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
IEEE Journal of Biomedical and Health Informatics|August 11, 2015
eClims: An Extensible and Dynamic Integration Framework for Biomedical Information SystemsMarinette Savonnet, Eric Leclercq, Pierre Naubourg
International Journal of Neonatal Screening|October 19, 2020
The Reliable, Automatic Classification of Neonates in First-Tier MALDI-MS Screening for Sickle Cell DiseaseMarven El Osta, Pierre Naubourg, Olivier Grunewald, et al.
International Journal of Neonatal Screening|October 19, 2020
A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS PlatformPierre Naubourg, Marven El Osta, David Rageot, et al.
Clinical Chemistry and Laboratory Medicine|February 14, 2024
MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLCMarven El Osta, Jean-François Benoist, Pierre Naubourg, et al.
Pageof 1